These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33947268)

  • 1. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry.
    Dubé K; Kanazawa J; Campbell C; Boone CA; Maragh-Bass AC; Campbell DM; Agosto-Rosario M; Stockman JK; Diallo DD; Poteat T; Johnson M; Saberi P; Sauceda JA
    AIDS Res Hum Retroviruses; 2022 Jan; 38(1):50-63. PubMed ID: 33947268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "It comes altogether as one:" perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States.
    Campbell DM; Dubé K; Cowlings PD; Dionicio P; Tam RM; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
    BMC Public Health; 2022 Jul; 22(1):1317. PubMed ID: 35810288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research.
    Dubé K; Kanazawa J; Dee L; Taylor J; Campbell DM; Brown B; Johnson MO; Saberi P; Sauceda JA; Sugarman J; Peluso MJ
    HIV Res Clin Pract; 2021 Feb; 22(1):14-30. PubMed ID: 33757411
    [No Abstract]   [Full Text] [Related]  

  • 4. A partner protection package for HIV cure-related trials involving analytical treatment interruptions.
    Dubé K; Morton T; Fox L; Dee L; Palm D; Villa TJ; Freshwater W; Taylor J; Graham G; Carter WB; Sauceda JA; Peluso MJ; Rid A
    Lancet Infect Dis; 2023 Oct; 23(10):e418-e430. PubMed ID: 37295453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the meaningful involvement of women in HIV cure-related research: a qualitative interview study in the United States.
    Dubé K; Barr E; Philbin M; Perez-Brumer A; Minalga B; Peterson B; Averitt D; Picou B; Martel K; Chung C; Mejía M; Cameron M; Graham G; Dee L; Dixon Diallo D; Gordon E; Korolkova A; Dyer T; Auerbach JD; Scully E; Dong KL; Gianella S
    HIV Res Clin Pract; 2023 Aug; 24(1):2246717. PubMed ID: 37608645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States.
    Bilger A; Plenn E; Barg FK; Rendle KA; Carter WB; Lamour-Harrington A; Jones N; Peterson B; Sauceda JA; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dubé K
    HIV Res Clin Pract; 2023 Oct; 24(1):2267825. PubMed ID: 37837376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States.
    Dubé K; Ndukwe SO; Korolkova A; Dee L; Sugarman J; Sauceda JA
    HIV Res Clin Pract; 2024 Jan; 25(1):2312318. PubMed ID: 38348830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies.
    Lau JSY; Smith MZ; Allan B; Martinez C; Power J; Lewin SR; McMahon JH
    AIDS Res Hum Retroviruses; 2020 Apr; 36(4):260-267. PubMed ID: 31608648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States.
    Dubé K; Kanazawa J; Dee L; Taylor J; Sauceda JA; Gianella S; Smith D; Deeks SG; Peluso MJ
    AIDS Res Ther; 2021 Oct; 18(1):75. PubMed ID: 34663375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "This Is Actually a Really Unique Moment in Time": Navigating Long-Acting HIV Treatment and HIV Cure Research with Analytical Treatment Interruptions-A Qualitative Interview Study in the United States.
    Dubé K; Perez-Brumer A; Patel H; Zhou C; Dee L; Graham G; Meanley S; Philbin MM
    AIDS Res Hum Retroviruses; 2024 Aug; 40(8):455-463. PubMed ID: 38386494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.
    Kanazawa J; Gianella S; Concha-Garcia S; Taylor J; Kaytes A; Christensen C; Patel H; Ndukwe S; Rawlings SA; Hendrickx S; Little S; Brown B; Smith D; Dubé K
    BMC Med Ethics; 2022 Jan; 23(1):2. PubMed ID: 35012544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States.
    Dubé K; Kanazawa J; Patel H; Louella M; Sylla L; Sheehy J; Dee L; Taylor J; Adair J; Anthony-Gonda K; Dropulić B; Sauceda JA; Peluso MJ; Deeks SG; Simoni J
    BMC Med Ethics; 2022 Apr; 23(1):39. PubMed ID: 35397551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.
    Dubé K; Evans D; Dee L; Sylla L; Taylor J; Skinner A; Weiner BJ; Greene SB; Rennie S; Tucker JD
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):67-79. PubMed ID: 28562069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions.
    Dubé K; Agarwal H; Carter WB; Dee L; Taylor J; Roebuck C; Peterson B; Patel H; Ndukwe S; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Bateman K; Howell BJ; Azzoni L; Mounzer K; Tebas P; Montaner LJ
    HIV Res Clin Pract; 2022 Aug; 23(1):76-90. PubMed ID: 35968737
    [No Abstract]   [Full Text] [Related]  

  • 15. "I Would Absolutely Need to Know That My Partner Is Still Going to be Protected": Perceptions of HIV Cure-Related Research Among Diverse HIV Serodifferent Couples in the United States.
    Dubé K; Agarwal H; Stockman JK; Auerbach JD; Sauceda JA; Conroy AA; Johnson MO
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):400-413. PubMed ID: 35972752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'With this study, we have hope that something is coming': community members' perceptions of HIV cure-related research in Durban, South Africa - a qualitative focus group study.
    Dubé K; Mthimkhulu D; Ngcobo W; Mindry D; Maphalala L; Pillay V; Tran W; Korolkova A; Ndung'u T; Dong K
    HIV Res Clin Pract; 2023 Jul; 24(1):2243046. PubMed ID: 37555592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption.
    Neergaard R; Jones NL; Roebuck C; Rendle KA; Barbati Z; Peterson B; Tebas P; Mounzer K; Metzger D; Montaner LJ; Dube K; Barg FK
    AIDS Res Hum Retroviruses; 2023 Aug; 39(8):414-421. PubMed ID: 35979886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding participant perspectives around HIV-1 cure-related studies involving antiretroviral analytical treatment interruptions in the United Kingdom.
    Lee MJ; Godakandaarachchi P; Collins S; Racz M; Sharp A; Fidler S; Fox J
    J Virus Erad; 2023 Dec; 9(4):100360. PubMed ID: 38188642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption.
    Okumu EA; Henderson GE; Golin C; Kuczynski K; Ormsby NQ; Peay HL
    J Virus Erad; 2023 Jun; 9(2):100331. PubMed ID: 37416088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States.
    Dubé K; Eskaf S; Hastie E; Agarwal H; Henley L; Roebuck C; Carter WB; Dee L; Taylor J; Mapp D; Campbell DM; Villa TJ; Peterson B; Lynn KM; Lalley-Chareczko L; Hiserodt E; Kim S; Rosenbloom D; Evans BR; Anderson M; Hazuda DJ; Shipley L; Bateman K; Howell BJ; Mounzer K; Tebas P; Montaner LJ
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.